Systems Level Physiology of the Basal Ganglia, and Pathophysiology of Parkinson's Disease

Parkinson's Disease

Volumn , Issue , 2008, Pages 55-63

  Wichmann, T ^a   DeLong, M R ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84882534439     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-0-12-374028-1.00005-1     Document Type: Chapter

References (55)

1. Aizman O., Brismar H., Uhlen P., Zettergren E., Levey A.I., Forssberg H., Greengard P., Aperia A. Anatomical and physiological evidence for D1 and D2 dopamine receptor colocalization in neostriatal neurons. Nat Neurosci 2000, 3:226-230.
2. Albin R.L., Young A.B., Penney J.B. The functional anatomy of basal ganglia disorders. Trends Neurosci 1989, 12:366-375.
3. Alexander G.E., Crutcher M.D. Functional architecture of basal ganglia circuits: Neural substrates of parallel processing. Trends Neurosci 1990, 13:266-271.
4. Alvarez L., Macias R., Lopez G., Alvarez E., Pavon N., Rodriguez-Oroz M.C., Juncos J.L., Maragoto C., Guridi J., Litvan I., Tolosa E.S., Koller W., Vitek J., DeLong M.R., Obeso J.A. Bilateral subthalamotomy in Parkinson's disease: Initial and long-term response. Brain 2005, 128:570-583.
5. Baron M.S., Vitek J.L., Bakay R.A.E., Green J., Kaneoke Y., Hashimoto T., Turner R.S., Woodard J.L., Cole S.A., McDonald W.M., DeLong M.R. Treatment of advanced Parkinson's disease by GPi pallidotomy: 1 year pilot-study results. Ann Neurol 1996, 40:355-366.
6. Bergman H., Wichmann T., DeLong M.R. Reversal of experimental parkinsonism by lesions of the subthalamic nucleus. Science 1990, 249:1436-1438.
7. Bergman H., Wichmann T., Karmon B., DeLong M.R. The primate subthalamic nucleus. II. Neuronal activity in the MPTP model of parkinsonism. J Neurophysiol 1994, 72:507-520.
8. Betarbet R., Sherer T.B., MacKenzie G., Garcia-Osuna M., Panov A.V., Greenamyre J.T. Chronic systemic pesticide exposure reproduces features of Parkinson's disease. Nat Neurosci 2000, 3:1301-1306.
9. Boraud T., Bezard E., Guehl D., Bioulac B., Gross C. Effects of L-DOPA on neuronal activity of the globus pallidus externalis (GPe) and globus pallidus internalis (GPi) in the MPTP-treated monkey. Brain Res 1998, 787:157-160.
10. Boraud T., Bezard E., Bioulac B., Gross C.E. Ratio of inhibited-to-activated pallidal neurons decreases dramatically during passive limb movement in the MPTP-treated monkey. J Neurophysiol 2000, 83:1760-1763.
11. Braak H., Del Tredici K., Rub U., de Vos R.A., Jansen Steur E.N., Braak E. Staging of brain pathology related to sporadic Parkinson's disease. Neurobiol Aging 2003, 24:197-211.
12. Brown P., Williams D. Basal ganglia local field potential activity: Character and functional significance in the human. Clin Neurophysiol 2005, 116:2510-2519.
13. Brown P., Oliviero A., Mazzone P., Insola A., Tonali P., Di Lazzaro V. Dopamine dependency of oscillations between subthalamic nucleus and pallidum in Parkinson's disease. J Neurosci 2001, 21:1033-1038.
14. Brown P., Mazzone P., Oliviero A., Altibrandi M.G., Pilato F., Tonali P.A., Di Lazzaro V. Effects of stimulation of the subthalamic area on oscillatory pallidal activity in Parkinson's disease. Exp Neurol 2004, 188:480-490.
15. Burns R.S., Chiueh C.C., Markey S.P., Ebert M.H., Jacobowitz D.M., Kopin I.J. A primate model of parkinsonism: Selective destruction of dopaminergic neurons in the pars compacta of the substantia nigra by N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine. Proc Natl Acad Sci USA 1983, 80:4546-4550.
16. Ceballos-Bauman A.O., Obeso J.A., Vitek J.L., DeLong M.R., Bakay R., Linaasoro G., Brooks D.J. Restoration of thalamocortical activity after posteroventrolateral pallidotomy in Parkinson's disease. Lancet 1994, 344:814.
17. Crossman A.R., Mitchell I.J., Sambrook M.A. Regional brain uptake of 2-deoxyglucose in N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)- induced parkinsonism in the macaque monkey. Neuro-pharmacology 1985, 24:587-591.
18. Day M., Wang Z., Ding J., An X., Ingham C.A., Shering A.F., Wokosin D., Ilijic E., Sun Z., Sampson A.R., Mugnaini E., Deutch A.Y., Sesack S.R., Arbuthnott G.W., Surmeier D.J. Selective elimination of glutamatergic synapses on striatopallidal neurons in Parkinson disease models. Nat Neurosci 2006, 9:251-259.
19. Dogali M., Fazzini E., Kolodny E., Eidelberg D., Sterio D., Devinsky O., Beric A. Stereotactic ventral pallidotomy for Parkinson's disease. Neurology 1995, 45:753-761.
20. Filion M., Tremblay L., Bedard P.J. Abnormal influences of passive limb movement on the activity of globus pallidus neurons in parkinsonian monkeys. Brain Res 1988, 444:165-176.
21. Gerfen C.R., Engber T.M., Mahan L.C., Susel Z., Chase T.N., Monsma F.J., Sibley D.R. D1 and D2 dopamine receptor-regulated gene expression of striatonigral and striatopallidal neurons. Science 1990, 250:1429-1432.
22. Gill S.S., Heywood P. Bilateral dorsolateral subthalamotomy for advanced Parkinson's disease [letter]. Lancet 1997, 350:1224.
23. Goldberg J.A., Boraud T., Maraton S., Haber S.N., Vaadia E., Bergman H. Enhanced synchrony among primary motor cortex neurons in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine primate model of Parkinson's disease. J Neurosci 2002, 22:4639-4653.
24. Grafton S., Waters C., Sutton J., Lew M., Couldwell W. Pallidotomy increases activity of motor association cortex in Parkinson's disease: A positron emission tomographic study. Ann Neurol 1995, 37:776-783.
25. Hashimoto T., Elder C.M., Okun M.S., Patrick S.K., Vitek J.L. Stimulation of the subthalamic nucleus changes the firing pattern of pallidal neurons. J Neurosci 2003, 23:1916-1923.
26. Heimer G., Bar-Gad I., Goldberg J.A., Bergman H. Dopamine replacement therapy reverses abnormal synchronization of pallidal neurons in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine primate model of parkinsonism. J Neurosci 2002, 22:7850-7855.
27. Heimer G., Rivlin-Etzion M., Bar-Gad I., Goldberg J.A., Haber S.N., Bergman H. Dopamine replacement therapy does not restore the full spectrum of normal pallidal activity in the 1-methyl-4-phenyl-1,2,3,6-tetra-hydropyridine primate model of parkinsonism. J Neurosci 2006, 26:8101-8114.
28. Ingham C.A., Hood S.H., Arbuthnott G.W. Spine density on neostriatal neurones changes with 6-hydroxydopamine lesions and with age. Brain Res 1989, 503:334-338.
29. Jaeger D., Gilman S., Aldridge J.W. Neuronal activity in the striatum and pallidum of primates related to the execution of externally cued reaching movements. Brain Res 1995, 694:111-127.
30. Kojima J., Yamaji Y., Matsumura M., Nambu A., Inase M., Tokuno H., Takada M., Imai H. Excitotoxic lesions of the pedunculopontine tegmental nucleus produce contralateral hemiparkinsonism in the monkey. Neurosci Lett 1997, 226:111-114.
31. Laitinen L.V. Pallidotomy for Parkinson's disease. Neurosurg Clin N Am 1995, 6:105-112.
32. Langston J.W., Ballard P., Tetrud J.W., Irwin I. Chronic parkinsonism in humans due to a product of meperidine-analog synthesis. Science 1983, 219:979-980.
33. Lei W., Jiao Y., Del Mar N., Reiner A. Evidence for differential cortical input to direct pathway versus indirect pathway striatal projection neurons in rats. J Neurosci 2004, 24:8289-8299.
34. Mallet N., Le Moine C., Charpier S., Gonon F. Feedforward inhibition of projection neurons by fast-spiking GABA interneurons in the rat striatum in vivo. J Neurosci 2005, 25:3857-3869.
35. Mallet N., Ballion B., Le Moine C., Gonon F. Cortical inputs and GABA interneurons imbalance projection neurons in the striatum of parkinsonian rats. J Neurosci 2006, 26:3875-3884.
36. Mena-Segovia J., Bolam J.P., Magill P.J. Pedunculopontine nucleus and basal ganglia: Distant relatives or part of the same family?. Trends Neurosci 2004, 27:585-588.
37. Miller W.C., DeLong M.R. Altered tonic activity of neurons in the globus pallidus and subthalamic nucleus in the primate MPTP model of parkinsonism. The Basal Ganglia II 1987, 415-427. Plenum Press, New York. M.B. Carpenter, A. Jayaraman (Eds.).
38. Nandi D., Aziz T.Z., Giladi N., Winter J., Stein J.F. Reversal of akinesia in experimental parkinsonism by GABA antagonist microinjections in the pedunculopontine nucleus. Brain 2002, 125:2418-2430.
39. Nini A., Feingold A., Slovin H., Bergman H. Neurons in the globus pallidus do not show correlated activity in the normal monkey, but phase-locked oscillations appear in the MPTP model of parkinsonism. J Neurophysiol 1995, 74:1800-1805.
40. Papa S.M., Desimone R., Fiorani M., Oldfield E.H. Internal globus pallidus discharge is nearly suppressed during levodopa-induced dyskinesias. Ann Neurol 1999, 46:732-738.
41. Pisani A., Centonze D., Bernardi G., Calabresi P. Striatal synaptic plasticity: Implications for motor learning and Parkinson's disease. Mov Disord 2005, 20:395-402.
42. Raju D.V., Shah D.J., Wright T.M., Hall R.A., Smith Y. Differential synaptology of vGluT2-containing thalamostriatal afferents between the patch and matrix compartments in rats. J Comp Neurol 2006, 499:231-243.
43. Raz A., Vaadia E., Bergman H. Firing patterns and correlations of spontaneous discharge of pallidal neurons in the normal and the tremulous 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine vervet model of parkinsonism. J Neurosci 2000, 20:8559-8571.
44. Raz A., Frechter-Mazar V., Feingold A., Abeles M., Vaadia E., Bergman H. Activity of pallidal and striatal tonically active neurons is correlated in MPTP-treated monkeys but not in normal monkeys. J Neurosci 2001, 21:RC128.
45. Samuel M., Ceballos-Baumann A.O., Turjanski N., Boecker H., Gorospe A., Linazasoro G., Holmes A.P., DeLong M.R., Vitek J.L., Thomas D.G., Quinn N.P., Obeso J.A., Brooks D.J. Pallidotomy in Parkinson's disease increases supplementary motor area and prefrontal activation during performance of volitional movements an H2(15)O PET study. Brain 1997, 120:1301-1313.
46. Smith Y., Raju D.V., Pare J.-F., Sidibe M. The thalamostriatal system: A highly specific network of the basal ganglia circuitry. Trends Neurosci 2004, 27:520-527.
47. Soares J., Kliem M.A., Betarbet R., Greenamyre J.T., Yamamoto B., Wichmann T. Role of external pallidal segment in primate parkinsonism: Comparison of the effects of MPTP-induced parkinsonism and lesions of the external pallidal segment. J Neurosci 2004, 24:6417-6426.
48. Stefani A., Lozano A.M., Peppe A., Stanzione P., Galati S., Tropepi D., Pierantozzi M., Brusa L., Scarnati E., Mazzone P. Bilateral deep brain stimulation of the pedunculopontine and subthalamic nuclei in severe Parkinson's disease. Brain 2007.
49. Stephens B., Mueller A.J., Shering A.F., Hood S.H., Taggart P., Arbuthnott G.W., Bell J.E., Kilford L., Kingsbury A.E., Daniel S.E., Ingham C.A. Evidence of a breakdown of corticostriatal connections in Parkinson's disease. Neuroscience 2005, 132:741-754.
50. Tepper J.M., Koos T., Wilson C.J. GABAergic microcircuits in the neostriatum. Trends Neurosci 2004, 27:662-669.
51. Trevitt T., Carlson B., Correa M., Keene A., Morales M., Salamone D. Interactions between dopamine D1 receptors and gamma-aminobutyric acid mechanisms in substantia nigra pars reticulata of the rat: Neurochemical and behavioral studies. Psychopharmacology 2002, 159:229-237.
52. Ungerstedt U. 6-Hydroxy-dopamine induced degeneration of central monoamine neurons. Eur J Pharmacol 1968, 5:107-110.
53. Wichmann T., Soares J. Neuronal firing before and after burst discharges in the monkey basal ganglia is predictably patterned in the normal state and altered in parkinsonism. J Neurophysiol 2006, 95:2120-2133.
54. Wichmann T., Bergman H., DeLong M.R. The primate subthalamic nucleus. I. Functional properties in intact animals. J Neurophysiol, 1994, 72:494-506.
55. Wilson C.J. Morphology and synaptic connections of crossed corticostriatal neurons in the rat. J Comp Neurol 1987, 263:567-580.